These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 19170803

  • 1. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
    Melo A, Rodrigues B, Nóbrega AC.
    J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
    [No Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG.
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of drooling with botulinum toxin type A in cerebral palsy].
    Duarte CS, Alves TR, Azeredo PM, Almeida SI.
    Rev Neurol; 2006 May; 49(11):610. PubMed ID: 19921629
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A, Panza F, Solfrizzi V, Frisardi V, Ranieri M, Fiore P.
    J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
    [No Abstract] [Full Text] [Related]

  • 7. The role of botulinum toxin in the management of head and neck cancer patients.
    Laskawi R, Ellies M.
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):112-6. PubMed ID: 17413413
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of sialorrhoea in neurological diseases with trans-dermic injections of botulinum toxin type A in the parotid glands].
    Carod Artal FJ.
    Neurologia; 2003 Jun; 18(5):280-4. PubMed ID: 12768517
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
    Khan WU, Campisi P, Nadarajah S, Shakur YA, Khan N, Semenuk D, McCann C, Roske L, McConney-Ellis S, Joseph M, Parra D, Amaral J, John P, Temple M, Connolly B.
    Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A.
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases.
    Kanazawa M, Shimohata T, Sato M, Onodera O, Tanaka K, Nishizawa M.
    Mov Disord; 2007 Mar 15; 22(4):597-8. PubMed ID: 17266083
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expanding use of botulinum toxin.
    Bhidayasiri R, Truong DD.
    J Neurol Sci; 2005 Aug 15; 235(1-2):1-9. PubMed ID: 15990116
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.